Total Payments
$571.66
2024 Payments
$121.45
Companies
9
Transactions
11
Medicare Patients
3,476
Medicare Billing
$714,373
Payment Breakdown by Category
Food & Beverage$511.69 (89.5%)
Education$59.97 (10.5%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $511.69 | 9 | 89.5% |
| Education | $59.97 | 2 | 10.5% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Bard Peripheral Vascular, Inc. | $147.02 | 1 | $0 (2022) |
| Otsuka America Pharmaceutical, Inc. | $105.00 | 1 | $0 (2019) |
| NxStage Medical, Inc. | $86.96 | 1 | $0 (2022) |
| Alexion Pharmaceuticals, Inc. | $60.22 | 2 | $0 (2024) |
| BAXTER HEALTHCARE | $49.61 | 1 | $0 (2018) |
| Bayer Healthcare Pharmaceuticals Inc. | $47.34 | 2 | $0 (2024) |
| GENZYME CORPORATION | $26.26 | 1 | $0 (2023) |
| AstraZeneca Pharmaceuticals LP | $24.64 | 1 | $0 (2024) |
| AKEBIA THERAPEUTICS INC | $24.61 | 1 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $121.45 | 5 | Bayer Healthcare Pharmaceuticals Inc. ($47.34) |
| 2023 | $26.26 | 1 | GENZYME CORPORATION ($26.26) |
| 2022 | $233.98 | 2 | Bard Peripheral Vascular, Inc. ($147.02) |
| 2020 | $35.36 | 1 | Alexion Pharmaceuticals, Inc. ($35.36) |
| 2019 | $105.00 | 1 | Otsuka America Pharmaceutical, Inc. ($105.00) |
| 2018 | $49.61 | 1 | BAXTER HEALTHCARE ($49.61) |
All Payment Transactions
11 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/10/2024 | Alexion Pharmaceuticals, Inc. | ULTOMIRIS (Biological) | Food and Beverage | In-kind items and services | $24.86 | General |
| Category: Rare Disease | ||||||
| 10/24/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $24.64 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 10/17/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $22.71 | General |
| Category: Cardio-renal | ||||||
| 09/25/2024 | AKEBIA THERAPEUTICS INC | Vafseo (Drug) | Education | In-kind items and services | $24.61 | General |
| Category: Nephrology | ||||||
| 09/05/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $24.63 | General |
| Category: Cardio-renal | ||||||
| 09/21/2023 | GENZYME CORPORATION | FABRAZYME (Biological) | Food and Beverage | In-kind items and services | $26.26 | General |
| Category: Genetic Disease | ||||||
| 09/29/2022 | NxStage Medical, Inc. | LIBERTY SELECT CYCLER (Device), NXSTAGE SYSTEM ONE | Food and Beverage | In-kind items and services | $86.96 | General |
| Category: Nephrology | ||||||
| 02/17/2022 | Bard Peripheral Vascular, Inc. | — | Food and Beverage | In-kind items and services | $147.02 | General |
| Category: BD Interventional Peripheral Intervention | ||||||
| 02/05/2020 | Alexion Pharmaceuticals, Inc. | Soliris (Drug) | Education | In-kind items and services | $35.36 | General |
| Category: Immunology | ||||||
| 06/13/2019 | Otsuka America Pharmaceutical, Inc. | JYNARQUE (Drug) | Food and Beverage | In-kind items and services | $105.00 | General |
| Category: NEPHROLOGY | ||||||
| 11/15/2018 | BAXTER HEALTHCARE | Renal - Non Product Related (Biological) | Food and Beverage | In-kind items and services | $49.61 | General |
| Category: Renal | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 6 | 805 | 2,367 | $510,434 | $179,010 |
| 2022 | 7 | 726 | 1,962 | $428,330 | $137,341 |
| 2021 | 10 | 824 | 2,248 | $586,241 | $182,510 |
| 2020 | 10 | 1,121 | 2,861 | $704,389 | $215,512 |
Total Patients
3,476
Total Services
9,438
Medicare Billing
$714,373
Procedure Codes
35
All Medicare Procedures & Services
35 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 192 | 720 | $162,720 | $63,102 | 38.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 172 | 659 | $133,118 | $44,524 | 33.4% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 136 | 548 | $87,132 | $31,960 | 36.7% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 171 | 209 | $67,089 | $19,732 | 29.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 61 | 156 | $36,348 | $13,477 | 37.1% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Facility | 2023 | 62 | 62 | $19,282 | $5,522 | 28.6% |
| 90935 | Hemodialysis procedure with physician evaluation | Facility | 2023 | 11 | 13 | $4,745 | $692.64 | 14.6% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 162 | 559 | $126,334 | $42,096 | 33.3% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 182 | 648 | $103,032 | $33,831 | 32.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 118 | 441 | $89,082 | $29,228 | 32.8% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 108 | 123 | $55,104 | $16,684 | 30.3% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 63 | 71 | $22,791 | $6,875 | 30.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 49 | 63 | $14,679 | $5,944 | 40.5% |
| 90935 | Hemodialysis procedure with physician evaluation | Facility | 2022 | 33 | 44 | $16,060 | $2,309 | 14.4% |
| 99231 | Follow-up hospital inpatient care per day, typically 15 minutes | Facility | 2022 | 11 | 13 | $1,248 | $373.15 | 29.9% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 153 | 525 | $118,650 | $40,776 | 34.4% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Facility | 2021 | 179 | 594 | $120,268 | $39,170 | 32.6% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 185 | 609 | $96,831 | $33,016 | 34.1% |
| 90960 | Dialysis services (4 or more physician visits per month), patient 20 years of age and older | Office | 2021 | 18 | 100 | $95,000 | $26,956 | 28.4% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 140 | 163 | $73,024 | $24,070 | 33.0% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2021 | 63 | 71 | $22,791 | $7,184 | 31.5% |
| 90945 | Dialysis procedure including one evaluation | Facility | 2021 | 19 | 93 | $33,945 | $6,007 | 17.7% |
| 90935 | Hemodialysis procedure with one physician evaluation | Facility | 2021 | 39 | 52 | $18,980 | $2,898 | 15.3% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Facility | 2021 | 15 | 16 | $4,352 | $1,706 | 39.2% |
| 99231 | Subsequent hospital inpatient care, typically 15 minutes per day | Facility | 2021 | 13 | 25 | $2,400 | $728.00 | 30.3% |
About Dr. Venkat Ram Rakesh Mundra, M.D
Dr. Venkat Ram Rakesh Mundra, M.D is a Nephrology healthcare provider based in Nashville, Tennessee. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/03/2012. The National Provider Identifier (NPI) number assigned to this provider is 1366706459.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Venkat Ram Rakesh Mundra, M.D has received a total of $571.66 in payments from pharmaceutical and medical device companies, with $121.45 received in 2024. These payments were reported across 11 transactions from 9 companies. The most common payment nature is "Food and Beverage" ($511.69).
As a Medicare-enrolled provider, Mundra has provided services to 3,476 Medicare beneficiaries, totaling 9,438 services with total Medicare billing of $714,373. Data is available for 4 years (2020–2023), covering 35 distinct procedure/service records.
Ad
Practice Information
- Specialty Nephrology
- Location Nashville, TN
- Active Since 07/03/2012
- Last Updated 10/01/2018
- Taxonomy Code 207RN0300X
- Entity Type Individual
- NPI Number 1366706459
Products in Payments
- JYNARQUE (Drug) $105.00
- LIBERTY SELECT CYCLER (Device) $86.96
- Renal - Non Product Related (Biological) $49.61
- Kerendia (Drug) $47.34
- Soliris (Drug) $35.36
- FABRAZYME (Biological) $26.26
- ULTOMIRIS (Biological) $24.86
- FARXIGA (Drug) $24.64
- Vafseo (Drug) $24.61
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Nephrology Doctors in Nashville
Dr. Jamie Dwyer, M.d, M.D
Nephrology — Payments: $549,974
Nephrology $549,974
Talat Ikizler, Md, MD
Nephrology — Payments: $240,153
Nephrology $240,153
Julia Lewis, Md, MD
Nephrology — Payments: $126,571
Nephrology $126,571
Dr. Volker Haase, M.d, M.D
Nephrology — Payments: $125,972
Nephrology $125,972
Alfred George, Md, MD
Nephrology — Payments: $51,836
Nephrology $51,836
Dr. Thomas Golper, Md, MD
Nephrology — Payments: $33,757
Nephrology $33,757